Results 191 to 200 of about 42,935 (312)

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. [PDF]

Cochrane Database Syst Rev, 2023
Theodoulou A, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J, Livingstone-Banks J, Hajizadeh A, Lindson N.   +8 more
europepmc   +1 more source

Nicotine withdrawal and depressive symptomatology during short-term smoking abstinence: a comparison of postmenopausal women using and not using hormone replacement therapy

, 2003
Sharon Allen, Sharon Allen, Sharon Allen
openalex   +1 more source

2-year infant and maternal outcomes investigating nicotine-replacement therapy for smoking cessation in pregnancy from the SNAP trial: a randomised controlled trial [PDF]

, 2013
Sue Cooper, Jaspal Taggar, Sarah Lewis, Neil Marlow, Anne Dickinson, Rachel Whitemore, Tim Coleman   +6 more
openalex   +1 more source

A Randomized Crossover Clinical Study to Assess the Effect of Oral Nicotine Pouches Used for Different Durations on Plasma Nicotine Pharmacokinetics in Healthy Oral Pouch Consumers

The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Oral nicotine pouches (NPs), although addictive and not risk‐free, have potential application for a tobacco harm reduction approach. This study aims to further characterize their ability to deliver nicotine effectively. This randomized seven‐way crossover PK study in healthy oral pouch consumers evaluated 11 and 20 mg NPs used for 10, 20, and ...
David Azzopardi, Elaine Brown, Filimon Meichanetzidis, Stacy Fiebelkorn, Linsey E. Haswell, George Hardie, Michael McEwan   +6 more
wiley   +1 more source

Testing oral nicotine pouches versus nicotine replacement therapy for cigarette harm reduction in Appalachia: The ARISE study protocol. [PDF]

PLoS One
Wermert A, Brasky TM, Newton AM, Hinton A, Curran H, Ferketich AK, Carpenter MJ, Shields PG, Tomko P, Wagener TL, Keller-Hamilton B.   +10 more
europepmc   +1 more source

Trends in Over-the-Counter Nicotine Replacement Therapy Sales, U.S., 2017‒2020. [PDF]

Am J Prev Med, 2023
Trigger S, Xu X, Malarcher A, Salazar E, Shin H, Babb S.   +5 more
europepmc   +1 more source

Was the Expansion of the Marketing License for Nicotine Replacement Therapy in the United Kingdom to Include Smoking Reduction Associated With Changes in Use and Incidence of Quit Attempts? [PDF]

, 2013
Emma Beard, Carla Bruguera, Jamie Brown, Ann McNeill, Robert West   +4 more
openalex   +1 more source

Olanzapine Attenuates Cue-elicited Craving for Tobacco

, 2004
Rationale: Recent biological conceptualizations of craving and addiction have implicated mesolimbic dopamine activity as a central feature of the process of addiction. Imaging, and pharmacological studies have supported a role for dopaminergic structures
Hutchinson, Kent E, Niaura, Raymond, Pickworth, Wallace B, Rutter Goodworth, Marie-Christine, Sobik, Laura, Swift, Robert   +5 more
core  

Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation

Alzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 1, January/March 2026.
Abstract INTRODUCTION Repurposing Food and Drug Administration (FDA)‐approved drugs could accelerate treatment development for Alzheimer's disease (AD). METHODS Using the MarketScan claims database (2011 to 2020), we applied a trial emulation approach in two base cohorts: (1) individuals with mild cognitive impairment (MCI cohort) and (2) individuals ...
Reina Tonegawa‐Kuji, Ehud Karavani, Michael Danziger, Pengyue Zhang, Yuan Hou, Yadi Zhou, Marina Bykova, Andrew A. Pieper, Michal Rosen‐Zvi, Jeffrey Cummings, Feixiong Cheng   +10 more
wiley   +1 more source

Risk of Stroke in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Cohort Study of 183,504 Subjects

Acta Psychiatrica Scandinavica, Volume 153, Issue 1, Page 54-64, January 2026.
ABSTRACT Background Major psychiatric disorder, including schizophrenia, bipolar disorder, and major depressive disorder, has been individually associated with increased risk of stroke. However, few studies have directly compared the stroke risk across these diagnostic groups within a unified cohort framework while accounting for stroke subtypes and ...
Mao‐Hsuan Huang, Chih‐Ming Cheng, Ju‐Wei Hsu, Ya‐Mei Bai, Tung‐Ping Su, Cheng‐Ta Li, Shih‐Jen Tsai, Yee‐Lam E. Chan, Mu‐Hong Chen   +8 more
wiley   +1 more source